Pinnacle Associates’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.28M Sell
59,600
-376
-0.6% -$29K 0.06% 285
2025
Q4
$4.76M Sell
59,976
-1,878
-3% -$148K 0.06% 257
2025
Q3
$4.66M Sell
61,854
-776
-1% -$53.2K 0.06% 257
2025
Q2
$4.32M Sell
62,630
-1,663
-3% -$109K 0.06% 258
2025
Q1
$4.36M Buy
64,293
+388
+0.6% +$23.2K 0.06% 254
2024
Q4
$2.87M Sell
63,905
-110,847
-63% -$6.22M 0.04% 319
2024
Q3
$13.8M Buy
174,752
+6,400
+4% +$373K 0.23% 119
2024
Q2
$9.94M Buy
168,352
+3,976
+2% +$249K 0.16% 158
2024
Q1
$13.1M Sell
164,376
-10,376
-6% -$793K 0.21% 120
2023
Q4
$13.8M Buy
174,752
+6,849
+4% +$487K 0.23% 120
2023
Q3
$11.7M Buy
167,903
+33,274
+25% +$2.36M 0.22% 122
2023
Q2
$9.31M Buy
134,629
+31,053
+30% +$2.21M 0.16% 154
2023
Q1
$7.7M Sell
103,576
-2,162
-2% -$181K 0.16% 156
2022
Q4
$9.85M Sell
105,738
-4,703
-4% -$454K 0.21% 130
2022
Q3
$10.5M Buy
110,441
+5,145
+5% +$509K 0.24% 125
2022
Q2
$9.76M Buy
105,296
+763
+0.7% +$74.5K 0.21% 135
2022
Q1
$10.6M Sell
104,533
-800
-0.8% -$84K 0.19% 146
2021
Q4
$10.9M Sell
105,333
-150
-0.1% -$13.9K 0.19% 137
2021
Q3
$8.95M Sell
105,483
-88,565
-46% -$7.42M 0.17% 146
2021
Q2
$16.2M Sell
194,048
-10,915
-5% -$894K 0.29% 101
2021
Q1
$15.4M Sell
204,963
-1,415
-0.7% -$103K 0.29% 101
2020
Q4
$14.1M Buy
206,378
+7,894
+4% +$513K 0.29% 100
2020
Q3
$11.6M Sell
198,484
-1,532
-0.8% -$95.3K 0.28% 100
2020
Q2
$13M Sell
200,016
-15,750
-7% -$992K 0.32% 89
2020
Q1
$12.8M Buy
215,766
+4,057
+2% +$271K 0.39% 75
2019
Q4
$15.7M Sell
211,709
-9,453
-4% -$664K 0.34% 84
2019
Q3
$13.9M Buy
221,162
+24,908
+13% +$1.48M 0.33% 82
2019
Q2
$10.7M Buy
196,254
+42,585
+28% +$2.29M 0.25% 113
2019
Q1
$8.29M Buy
153,669
+5,143
+3% +$317K 0.19% 146
2018
Q4
$9.73M Sell
148,526
-2,169
-1% -$162K 0.25% 112
2018
Q3
$11.9M Buy
150,695
+799
+0.5% +$57.1K 0.25% 116
2018
Q2
$9.65M Buy
149,896
+26,218
+21% +$1.73M 0.2% 140
2018
Q1
$7.69M Sell
123,678
-17,619
-12% -$1.26M 0.15% 164
2017
Q4
$10.2M Sell
141,297
-33,216
-19% -$2.41M 0.2% 131
2017
Q3
$14.2M Sell
174,513
-26,395
-13% -$2.09M 0.26% 102
2017
Q2
$16.2M Sell
200,908
-26,469
-12% -$2.09M 0.31% 89
2017
Q1
$17.8M Buy
227,377
+25,687
+13% +$2.05M 0.34% 85
2016
Q4
$15.9M Sell
201,690
-69,991
-26% -$5.66M 0.32% 87
2016
Q3
$24.2M Sell
271,681
-3,963
-1% -$374K 0.48% 63
2016
Q2
$26.4M Buy
275,644
+2,962
+1% +$295K 0.57% 50
2016
Q1
$28.3M Buy
272,682
+12,970
+5% +$1.26M 0.61% 42
2015
Q4
$25.4M Buy
259,712
+1,603
+0.6% +$157K 0.53% 49
2015
Q3
$24.9M Sell
258,109
-5,442
-2% -$572K 0.55% 53
2015
Q2
$27.6M Sell
263,551
-3,955
-1% -$404K 0.51% 54
2015
Q1
$27.6M Sell
267,506
-12,540
-4% -$1.27M 0.52% 54
2014
Q4
$27M Sell
280,046
-2,740
-1% -$241K 0.53% 49
2014
Q3
$22.5M Sell
282,786
-6,934
-2% -$547K 0.46% 66
2014
Q2
$21.8M Sell
289,720
-11,886
-4% -$898K 0.43% 65
2014
Q1
$22.6M Buy
301,606
+4,000
+1% +$283K 0.44% 64
2013
Q4
$21.3M Sell
297,606
-8,761
-3% -$563K 0.42% 68
2013
Q3
$17.4M Sell
306,367
-12,378
-4% -$738K 0.36% 79
2013
Q2
$18.2M Buy
+318,745
New +$18.5M 0.41% 72

Other funds holding CVS

Pinnacle Associates's CVS Position: Q1 2026 in Review

Pinnacle Associates reduced its CVS Health (CVS) stake by 0.63% in Q1 2026, selling an estimated $29K and leaving 59,600 shares worth $4.28M. The position accounts for 0.06% of the portfolio, ranked #285.

Pinnacle Associates first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $28.3M in Q1 2016. 1,868 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Pinnacle Associates held 59,600 shares of CVS Health worth $4.28M as of Q1 2026.
  • Pinnacle Associates sold 376 CVS Health shares in Q1 2026, an estimated $29K.
  • CVS Health made up 0.06% of Pinnacle Associates's portfolio in Q1 2026, its #285 holding.
  • Pinnacle Associates first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Pinnacle Associates's CVS Health position peaked at $28.3M in Q1 2016.
  • 1,868 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Pinnacle Associates's 13F filing for Q1 2026, filed 22 Apr 2026.